Skip to main navigation Skip to search Skip to main content

Hyaluronic acid-based nanocomplexes as novel drug-nanocarriers to treat myotonic dystrophy

  • M. Repellin
  • , Flavia CARTON
  • , F. Boschi
  • , A. Albano
  • , G. Lollo
  • , M. Malatesta

Research output: Contribution to journalArticlepeer-review

Abstract

Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myotonic dystrophy
Original languageEnglish
Pages (from-to)27-28
Number of pages2
JournalEuropean Journal of Histochemistry
Publication statusPublished - 1 Jan 2019

Keywords

  • nanoparticles
  • hyaluronic acid
  • myotonic dystrophy

Fingerprint

Dive into the research topics of 'Hyaluronic acid-based nanocomplexes as novel drug-nanocarriers to treat myotonic dystrophy'. Together they form a unique fingerprint.

Cite this